Moreover, pathways related to the cell cycle, the P53 pathway, MTORC1 signaling, KRAS signaling, angiogenesis and response to ionizing radiation may be the key pathways regulated by IER5 in glioma patients. This evidence concerns the gene KRAS and central nervous system cancer.